Literature DB >> 18030119

Orbital exenteration: a 15-year study of 38 cases.

Arie Y Nemet1, Peter Martin, Ross Benger, Georgina Kourt, Vidushi Sharma, Raf Ghabrial, Jenny Danks.   

Abstract

PURPOSE: To determine the clinical indications and outcomes after orbital exenteration when histologic margins were reported as "clear," examining factors affecting local and systemic recurrences and mortality.
METHODS: Retrospective case review of exenterations performed in Sydney Eye Hospital in Sydney, Australia, between 1990 and 2004. Reviewed data indications for exenteration, histopathologic diagnosis, and recurrences on follow-up.
RESULTS: Secondary intraorbital spread of malignant adnexal tumors was the most common indication for exenteration (34 of 38). Among these, the site of the primary neoplasm was the eyelid in 19 cases and the ocular surface in 12 cases. Exenteration was total in 26 cases, subtotal in 8 cases, and extended in 4 cases. In 11 cases, a dermis-fat graft was used for socket reconstruction; 24 cases were allowed to granulate spontaneously. The average healing time was 5 months (range, 4-6 months) for spontaneous granulation, and 6 weeks (range, 4-8 weeks) for dermis-fat grafts. Perineural spread was demonstrated histopathologically in 7 specimens. During follow-up (median, 48 months), there were 9 recurrences (23.7%): 3 local and 6 systemic. Seven patients (18.4%) died of the disease during the follow-up period.
CONCLUSIONS: Dermis-fat grafts for reconstruction of the exenterated socket seem to optimize the aesthetic results. The first year is the most important period for follow-up of local recurrences, but systemic examination is needed for the longer follow-up. This may have implications in terms of reconstruction and adjunctive treatment following exenteration surgery.

Entities:  

Mesh:

Year:  2007        PMID: 18030119     DOI: 10.1097/IOP.0b013e318158e994

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  9 in total

Review 1.  Considerations in Orbital Exenteration.

Authors:  Mofiyinfolu Sokoya; Jason E Cohn; Scott Kohlert; Thomas Lee; Sameep Kadakia; Yadranko Ducic
Journal:  Semin Plast Surg       Date:  2019-04-26       Impact factor: 2.314

2.  Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival.

Authors:  R C Gerring; C T Ott; J M Curry; Z B Sargi; S T Wester
Journal:  Eye (Lond)       Date:  2016-10-21       Impact factor: 3.775

3.  Sino-orbital cutaneous fistula with endoscopy guided technique: A case series.

Authors:  Yunia Irawati; Retno Sulistyo Wardani; Michelle Eva Rebeca Natalia; Neni Anggraini
Journal:  Int J Surg Case Rep       Date:  2022-05-13

4.  Naso- or Orbitocutaneous Fistulas after Free Flap Reconstruction of Orbital Exenteration Defects: Retrospective Study, Systematic Review, and Meta-Analysis.

Authors:  Patrick Tassone; Kurren S Gill; David Hsu; Gurston Nyquist; Howard Krein; Jurij R Bilyk; Anna P Murchison; James J Evans; Ryan N Heffelfinger; Joseph M Curry
Journal:  J Neurol Surg B Skull Base       Date:  2017-03-16

Review 5.  Perineural Spread of Head and Neck Cancer: Ophthalmic Considerations.

Authors:  Thomas Benton Ableman; Steven A Newman
Journal:  J Neurol Surg B Skull Base       Date:  2016-04

6.  Ocular surface tumors.

Authors:  Ihab Saad Othman
Journal:  Oman J Ophthalmol       Date:  2009-01

7.  Clinico-Pathological Patterns of Patients Who Underwent Orbital Exenteration in a Tertiary Eye Hospital of Nepal.

Authors:  Limbu Ben; Mengesha Aemero; Anya G Gushchin; Grant H Moore; Saiju Rohit
Journal:  Ethiop J Health Sci       Date:  2016-11

8.  Factors related to survival outcomes following orbital exenteration: a retrospective, comparative, case series.

Authors:  Orapan Aryasit; Passorn Preechawai; Chakree Hirunpat; Orasa Horatanaruang; Penny Singha
Journal:  BMC Ophthalmol       Date:  2018-07-28       Impact factor: 2.209

Review 9.  Epidemiology of ocular surface squamous neoplasia in Africa.

Authors:  Stephen Gichuhi; Mandeep S Sagoo; Helen A Weiss; Matthew J Burton
Journal:  Trop Med Int Health       Date:  2013-10-30       Impact factor: 2.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.